209 related articles for article (PubMed ID: 25494412)
1. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
[TBL] [Abstract][Full Text] [Related]
2. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
[TBL] [Abstract][Full Text] [Related]
3. Individual volume-based 3D gamma indices for pretreatment VMAT QA.
Yi J; Han C; Zheng X; Zhou Y; Deng Z; Xie C; Jin X; Jin F
J Appl Clin Med Phys; 2017 May; 18(3):28-36. PubMed ID: 28318101
[TBL] [Abstract][Full Text] [Related]
4. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment 2D and 3D dosimetric verification of volumetric arc therapy. A correlation study between gamma index passing rate and clinical dose volume histogram.
Szczurek L; Juszkat R; Szczurek J; Turek I; Sosnowski P
PLoS One; 2019; 14(8):e0221086. PubMed ID: 31408486
[TBL] [Abstract][Full Text] [Related]
7. Implementation of TG-218 for patient-specific quality assurance tolerance and action limits determination: Gamma passing rate evaluation using 3DVH software.
Stasinou D; Patatoukas G; Kollaros N; Diamantopoulos S; Kypraiou E; Kougioumtzopoulou A; Kouloulias V; Efstathopoulos E; Platoni K
Med Phys; 2022 Jul; 49(7):4322-4334. PubMed ID: 35560362
[TBL] [Abstract][Full Text] [Related]
8. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
10. Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
Infusino E; Mameli A; Conti R; Gaudino D; Stimato G; Bellesi L; D'Angelillo RM; Ramella S; Benassi M; Trodella L
Med Dosim; 2014; 39(3):276-81. PubMed ID: 25088815
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
12. Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.
Han C; Yu W; Zheng X; Zhou Y; Gong C; Xie C; Jin X
J Radiat Res; 2018 Sep; 59(5):669-676. PubMed ID: 30085157
[TBL] [Abstract][Full Text] [Related]
13.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
14. A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA.
Alhazmi A; Gianoli C; Neppl S; Martins J; Veloza S; Podesta M; Verhaegen F; Reiner M; Belka C; Parodi K
Phys Med Biol; 2018 May; 63(11):115002. PubMed ID: 29714714
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gamma index based on dosimetric error and clinically relevant dose-volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy.
Kaneko A; Sumida I; Mizuno H; Isohashi F; Suzuki O; Seo Y; Otani K; Tamari K; Ogawa K
Radiat Oncol; 2019 Feb; 14(1):36. PubMed ID: 30808377
[TBL] [Abstract][Full Text] [Related]
16. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of ArcCheck and film verification for VMAT in the treatment of nasopharyngeal carcinoma].
Yi J; Jin X; Zhou Y; Han C; Zheng X; Wu Z; Huang K; Xie C
Zhongguo Yi Liao Qi Xie Za Zhi; 2013 May; 37(3):228-31. PubMed ID: 24015624
[TBL] [Abstract][Full Text] [Related]
18. Correlation analysis between 2D and quasi-3D gamma evaluations for both intensity-modulated radiation therapy and volumetric modulated arc therapy.
Kim JI; Choi CH; Wu HG; Kim JH; Kim K; Park JM
Oncotarget; 2017 Jan; 8(3):5449-5459. PubMed ID: 27690300
[TBL] [Abstract][Full Text] [Related]
19. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.
Masi L; Doro R; Favuzza V; Cipressi S; Livi L
Med Phys; 2013 Jul; 40(7):071718. PubMed ID: 23822422
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of constant dose rate VMAT in the treatment of nasopharyngeal cancer patients.
Yu W; Shang H; Xie C; Han C; Yi J; Zhou Y; Jin X
Radiat Oncol; 2014 Nov; 9():235. PubMed ID: 25366034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
